FEMY supply chain intelligence for Femasys Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Femasys Inc. (FEMY) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| U-S-CUSTOMERS | U-S-CUSTOMERS | 92% | The majority of products sold directly to U.S. customers are shipped via common carrier, and the customer pays for shipping and handling and assumes control Free on Board (FOB) shipping point. |
| BOSTON-IVF | BOSTON-IVF | 90% | In October and December 2024 and March 2025, we announced partnerships with prominent infertility center conglomerates, Boston IVF, HRC Fertility, and CNY Fertility, respectively. |
| CNY-FERTILITY | CNY-FERTILITY | 90% | In October and December 2024 and March 2025, we announced partnerships with prominent infertility center conglomerates, Boston IVF, HRC Fertility, and CNY Fertility, respectively. |
| HRC-FERTILITY | HRC-FERTILITY | 90% | In October and December 2024 and March 2025, we announced partnerships with prominent infertility center conglomerates, Boston IVF, HRC Fertility, and CNY Fertility, respectively. |
| BAYER-AG | BAYER-AG | 85% | facturing, and Supply Agreement with Bayer Yakuhin, Ltd., a wholly owned subsidiary of Bayer AG, in 2012. The Company sells products based on purchase orders provided by Bayer Yakuhin in accordance w… |
| BAYER-YAKUHIN-LTD | BAYER-YAKUHIN-LTD | 85% | facturing, and Supply Agreement with Bayer Yakuhin, Ltd., a wholly owned subsidiary of Bayer AG, in 2012. The Company sells products based on purchase orders provided by Bayer Yakuhin in accordance w… |
| KEBOMED-EUROPE-AG | KEBOMED-EUROPE-AG | 85% | r agreements. Control and risk of ownership transfer at the time of shipment and the Company records revenue at that time. The Company entered in a distributor agreement with Kebomed Europe AG (“Kebo… |
| FEMVUE-CUSTOMERS | FEMVUE-CUSTOMERS | 80% | Over 50% of the practices representing approximately 60% of the assisted reproduction cycles performed are located in 8 states, and are prioritized, along with the existing FemVue customers. |
| AVAILABLE-INFORMATION-FEMASYS-INC | AVAILABLE-INFORMATION-FEMASYS-INC | 62% | ces in the EU, we must obtain and maintain a CE marking demonstrating compliance with the MDR. 25 Table of Contents Other Regions Most major markets have different levels of regulatory requirements f… |
| COOK-MEDICAL-LLC | COOK-MEDICAL-LLC | 62% | ventory at the supplier and second sourcing approaches for specific suppliers. Typically, our outside vendors produce components to our specifications and in many instances to our designs. Our suppli… |
| EXHIBITS-INCORPORATED | EXHIBITS-INCORPORATED | 62% | ancing into which we enter may impose upon us covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stoc… |
| ROCKET-MEDICAL-LLC | ROCKET-MEDICAL-LLC | 62% | ventory at the supplier and second sourcing approaches for specific suppliers. Typically, our outside vendors produce components to our specifications and in many instances to our designs. Our suppli… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| FEMY-DEBT | Debt stack $4.7M | 90% | Market cache reports total debt of $4.7M. |
| FEMY-DEBT-9470 | Warrants outstanding: 500 | 90% | xbrl warrant detail from xbrl 2025-12-31. |
| FEMY-DEBT-9471 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| FEMY-OWNER-DAUNTLESS-INVESTMENT-GROUP-LLC | Dauntless Investment Group, LLC | 90% | 13F overlay lists Dauntless Investment Group, LLC as top holder; 38 tracked holders. |